Co-Diagnostics, Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Salt Lake City, UT
CODX chart
What traders are saying about $CODX
Latest postsCo-Diagnostics, Inc. news
- bioAffinity Technologies Expands Lung Diagnostics Pipeline into COPD and Asthma
Proactive financial news ·
- Microbix’s Diagnostics and Quality-Control Portfolio Draws Attention Ahead of Investor Updates (TSX:MBX)
kalkine.ca ·
- FDA Clears Sekisui Diagnostics Rapid COVID-19 and Flu A&B Combo Test
Clinical Lab Products ·
- Quest Diagnostics data breach hits patient records in lab system
Top Class Actions ·
- Sekisui Diagnostics’ COVID/Flu Rapid Test 510(k) Gets FDA Clearance, CLIA Waiver
GenomeWeb ·
- SEKISUI Diagnostics Announces 510(k) Clearance and Launch of the OSOM® COVID-19/Flu A&B Combo Test
PR Newswire ·
- Quest Diagnostics says patient records were accessed through its Quanum lab-ordering portal; the number of affected people and exposed data remain unknown
Medical Daily ·
- Quest Diagnostics Confirms Cyber Breach, Patient Records May Be Exposed
The420.in ·
- Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
Yahoo Finance ·
- EXCLUSIVE: Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
Benzinga ·
- Quest Diagnostics Incorporated (DGX) Stock Forecasts
Yahoo Finance ·
- GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?
TradingView ·
Co-Diagnostics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $622,489 | $3.9M | $6.8M | $34.2M |
| Net income | -$47.0M | -$38.0M | -$35.3M | -$14.2M |
| Diluted EPS | $-35.25 | $-37.22 | $-1.20 | $-0.45 |
| Total assets (year end) | $24.7M | $63.6M | $95.3M | $123.1M |
| Cash and equivalents (year end) | $11.9M | $2.9M | $14.9M | $23.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Co-Diagnostics, Inc.
- Ticker
- CODX (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Salt Lake City, UT
- Incorporated in
- UT
- Fiscal year end
- December 31
- SEC CIK
- 1692415
Frequently asked questions
What exchange is Co-Diagnostics, Inc. listed on?
Co-Diagnostics, Inc. trades on the Nasdaq under the ticker symbol CODX.
What industry is Co-Diagnostics, Inc. in?
Co-Diagnostics, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Co-Diagnostics, Inc. headquartered?
Co-Diagnostics, Inc.'s business address on file with the SEC is in Salt Lake City, UT.
When does Co-Diagnostics, Inc.'s fiscal year end?
Co-Diagnostics, Inc.'s fiscal year ends on December 31.
How much revenue did Co-Diagnostics, Inc. report?
Co-Diagnostics, Inc. reported $622,489 in revenue for calendar year 2025, according to its SEC filings.